VX-135

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VX-135, covering 2015-04-16 to 2017-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C [Phase 2]

See pricing